Related Experiment Videos
A chimeric T cell receptor with super-signaling properties
Troels R Petersen1, Sven Gülland, Estelle Bettelli
1Malaghan Institute of Medical Research, Wellington, New Zealand.
International Immunology
|May 19, 2004
Summary
Altering the T-cell receptor beta chain with gamma chain components significantly enhances T-cell sensitivity to antigen stimulation. This finding may offer new targets for treating autoimmune diseases like multiple sclerosis.
Area of Science:
- Immunology
- Molecular Biology
- Cell Signaling
Background:
- The relationship between T-cell receptor (TCR) structure and function is not fully understood.
- How TCR-alpha-beta (TCR-αβ) chains recognize antigens and activate downstream signaling via CD3-gamma-delta-epsilon/zeta (CD3-γδε/ζ) complex remains a key question.
- Investigating the specific domains of the TCR-beta chain involved in TCR signaling is crucial for understanding T-cell activation.
Purpose of the Study:
- To determine which part of the TCR-beta chain influences TCR signaling.
- To investigate the functional consequences of modifying the TCR-beta chain's constant regions.
Main Methods:
- Exchanging domains of the constant regions of the TCR-beta chain with corresponding TCR-gamma chain domains.
- Generating hybridoma cells and transgenic mice expressing chimeric TCR-beta chains (betaIII) with wild-type TCR-alpha (alphawt) chains.
- Assessing T-cell sensitivity to antigenic stimulation and TCR association with CD3-γδε/ζ complex.
Main Results:
- Hybridoma cells expressing alphawt/betaIII chimeric TCR demonstrated a 10-fold increase in sensitivity to antigenic stimulation compared to cells with wild-type TCR-αβ.
- This super-signaling phenotype was observed in TCRs specific for both alloantigens and autoantigens.
- Transgenic T cells expressing the chimeric alphawt/betaIII TCR also exhibited enhanced signaling upon antigen exposure.
- The chimeric TCR maintained normal association with CD3-γδε/ζ complex.
Conclusions:
- Intracellular and transmembrane domains of the TCR-gamma chain, when incorporated into the TCR-beta chain, enhance TCR signaling efficiency.
- This enhanced TCR signaling has implications for understanding T-cell activation in autoimmunity.
- Targeting molecules involved in this enhanced signaling pathway could offer new therapeutic strategies for autoimmune disorders such as multiple sclerosis.